Recent News

Investor Relations
Leveraged Lending
Life Sciences
Real Estate
May 5, 2022

Pliant Therapeutics Enters into $100 million Loan Facility Agreement with Oxford Finance to Support Ongoing Development of PLN-74809

News | Life Sciences
April 25, 2022

Oxford Finance Healthcare Real Estate Q1 2022 Recap

News | Healthcare | Real Estate
April 5, 2022

Oxford Finance Announces the Closing of a $75 Million Credit Facility With Fusion Pharmaceuticals

News | Life Sciences
March 28, 2022

Verastem Oncology Provides Financial Update to Support Development of VS-6766 and Defactinib in RAS Pathway-Driven Tumors

News | Life Sciences
March 24, 2022

Oxford Finance Leads $660 Million Upsize Financing for Specialty Dental Brands

News | Healthcare | Leveraged Lending
March 17, 2022

Lexicon Enters Into Loan Facility With Oxford Finance for Up to $150 Million to Support Planned Commercialization of Sotagliflozin

News | Life Sciences
February 23, 2022

Rohit Gandhi Joins Oxford Finance’s Senior Lending Platform

News | Healthcare
February 15, 2022

Oxford Finance Announces the Closing of a $50 Million Credit Facility With OncoResponse

News | Life Sciences
February 14, 2022

Oxford Finance’s Healthcare Real Estate Group Closes Over $540 Million of Capital Commitments in 2021

News | Healthcare | Real Estate
February 7, 2022

Oxford Finance Closes $400 Million Senior Note Offering

News | Investor Relations
February 1, 2022

CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan

News | Life Sciences
January 27, 2022

Sierra Oncology Provides Financial Update to Support the Future Commercialization of Momelotinib

News | Life Sciences

Meet the team that speaks your language.